The tumour-on-a-chip system has been used to model HGSC using CRISPR-Cas9 edited TP53 knockouts in dog oviductal epithelia, wherein cells lost normal morphology, exhibited increased proliferation and DNA double strand breaks [98]. The gene discussed is TP53; the disease is neoplasm.